Dyne Therapeutics to participate in upcoming investor conferences
Dyne Therapeutics said management is scheduled to participate in upcoming investor conferences.
WALTHAM, Mass., Sept.
02, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc.
NASDAQ:DYN, a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that management is scheduled to participate in the following…